RXRX

RXRX

USD

Recursion Pharmaceuticals Inc. Class A Common Stock

$5.000-0.200 (-3.846%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$5.200

Hoch

$5.320

Tief

$4.970

Volumen

57.15M

Unternehmensfundamentaldaten

Marktkapitalisierung

2.2B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

39.05M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $3.79Aktuell $5.000Hoch $12.36

Ähnliche Nachrichten

GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following

Mehr anzeigen
Recursion to Participate in Upcoming Investor Conferences
GlobeNewswire

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and

Mehr anzeigen
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Reuters

Buybacks take backseat as AI drives record US capex spending

Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.

Mehr anzeigen
Buybacks take backseat as AI drives record US capex spending